Screener
Novanta NOVT Medical Solutions — Inventory Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Novanta’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335404
| Line item | July 3, 2026 | December 31, 2025 |
|---|---|---|
| Automation Enabling Technologies | $80,647 | $76,685 |
| Medical Solutions | 98,101 | 108,195 |
| Total accounts receivable | $178,748 | $184,880 |
| Inventories | ||
| Automation Enabling Technologies | $116,428 | $110,205 |
| Medical Solutions | 76,281 | 78,079 |
| Total inventories | $192,709 | $188,284 |
| Total segment assets | $371,457 | $373,164 |
Item 1. Financial Statements
FAQ
- What is Novanta's medical solutions — inventory net?
- Novanta (NOVT) reported medical solutions — inventory net of $76.28M in Q2 2026.
- How has Novanta's medical solutions — inventory net changed year-over-year?
- Novanta's medical solutions — inventory net increased by 5.9% year-over-year, from $72.02M to $76.28M.
- What does medical solutions — inventory net mean?
- This reflects the total value of raw materials, work-in-progress, and finished goods held by the segment, net of any valuation reserves. It provides insight into the segment's supply chain management, production efficiency, and ability to meet market demand. Excessive inventory levels may indicate overproduction or slowing sales, while low levels could suggest supply chain constraints.
Ask your AI about Novanta's medical solutions — inventory net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude